Trial
NCT06904274
Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Bayer
Collaborators
—
Condition
Endometrial Hyperplasia
Intervention
BAY865028
Why stopped
Bayer cancelled study 22923 due to enrollment challenges, including difficulties identifying eligible patients, participation requirements, and site burden. The decision was unrelated to safety and does not change Mirena's benefit-risk profile.
Provenance
Dataset: 2026-07-31 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-30